Acrivon Therapeutics, Inc. logo

Acrivon Therapeutics, Inc.

ACRVNASDAQ

Acrivon Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Peter Blume-Jensen, with a market cap of $79.8M. As of Q3 2025, 56% of shares are held by 45 institutional investors, with RA CAPITAL MANAGEMENT, LLC as the largest holder at 26.52%.

CEOPeter Blume-Jensen
Market Cap$79.8M
Biotechnology
Healthcare
Employees61.0
Country
United States of America

Overview

Overview of institutional ownership in ACRV as of Q3 2025 with a market cap of $56.9M

All Institutions

Institutions
45
Value Held
$31.6M
Shares Held
17.5M
Avg Position
$702.3K
Median Position
$41.4K

Hedge Funds

Hedge Funds
9
Value Held
$20.5M
Shares Held
11.3M
Avg Position
$2.3M
Median Position
$335.3K

Ownership Breakdown

Institutional (non-HF): 19.53%Institutional (non-HF)Hedge Funds: 35.98%Hedge FundsRetail & Other: 44.49%Retail & Other
Institutional (non-HF)
19.53%
$11.1M
Hedge Funds
35.98%
$20.5M
Retail & Other
44.49%
$25.3M

Based on market cap of $56.9M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in ACRV as of Q3 2025

InstitutionPosition Value
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$15.1M
0.19% of portfolio
$3.8M
0.84% of portfolio
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$2.8M
0.00% of portfolio
$1.6M
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$1.2M
0.00% of portfolio
$1.1M
0.00% of portfolio
$1.1M
0.00% of portfolio
$733.5K
0.37% of portfolio
B
BlackRock, Inc.
Institution
$599.0K
0.00% of portfolio
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
$577.8K
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for ACRV in Q3 2025

Traded
$169.8K
Buyers
15
Sellers
29
Total Bought
+$2.3M
Total Sold
$2.4M
Avg Position
$554.5K

Biggest Buyers

InstitutionNet Bought
UBS Group AG logo
UBS Group AG
Institution
+$1.2M
+682.8K shares
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
+$249.8K
+138.0K shares
+$206.5K
+114.1K shares
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
+$188.1K
+103.9K shares
+$166.5K
+92.0K shares
+$80.8K
+44.6K shares
+$59.6K
+32.9K shares
+$50.1K
+27.7K shares
+$19.3K
+10.7K shares
+$1.7K
+917.0 shares

Biggest Sellers

InstitutionNet Sold
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$641.1K
354.2K shares
$454.9K
382.2K shares
$217.8K
120.3K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$200.9K
111.0K shares
H
$173.6K
145.9K shares
B
BlackRock, Inc.
Institution
$138.8K
76.7K shares
X
XTX Topco Ltd
Institution
$127.0K
70.2K shares
S
Squarepoint Ops LLC
Hedge FundQuant
$87.4K
48.3K shares
$75.7K
63.6K shares
$57.0K
31.5K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited ACRV in Q3 2025

New Positions
3
New Value
$248.0K
Exited Positions
11
Exited Value
$857.3K

New Positions

InstitutionPosition Value
$166.5K
92.0K shares
$80.8K
44.6K shares
$675.0
373.0 shares

Exited Positions

InstitutionPrevious Position
$454.9K
382.2K shares
H
$173.6K
145.9K shares
$75.7K
63.6K shares
$52.2K
43.9K shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$26.5K
22.3K shares
$26.3K
22.2K shares
$18.2K
15.3K shares
$15.1K
12.7K shares
G
Ground Swell Capital, LLC
Hedge FundMulti-Strategy
$14.5K
12.2K shares
$210.0
176.0 shares

Options Activity

Institutions with the largest Call and Put options positions in ACRV as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with ACRV as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.84%
$3.8M
0.37%
$733.5K
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
0.19%
$15.1M
0.01%
$19.3K
X
XTX Topco Ltd
Institution
0.00%
$65.1K
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
0.00%
$2.8M
0.00%
$1.1M
0.00%
$80.8K
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
0.00%
$577.8K
0.00%
$41.4K

Hedge Fund Spotlight

Discover hedge funds investing in ACRV

B
BAKER BROS. ADVISORS LP
Hedge FundSector
Portfolio ManagerScott Lawrence Lessing
Portfolio Value
$10.8B
Positions
88
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 95.20%Healthcare
Acrivon Therapeutics, Inc. logo

Position in Acrivon Therapeutics, Inc.

Market Value
$41.3K
Shares Held
22.8K
Portfolio Weight
0.00%
Owned Since
2024-Q1
Top HoldingSectorMarket ValueWeight
1
Incyte logo
Incyte
INCY
Biotechnology
Healthcare
$2.6B24.14%
Biotechnology
Healthcare
$982.3M9.10%
3
Insmed logo
Insmed
INSM
Biotechnology
Healthcare
$965.4M8.94%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.